How should potassium levels be managed in a patient with end-stage renal disease on maintenance dialysis to prevent hyperkalemia or hypokalemia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board

Educational purpose only • Exercise caution as content is pending human review

Article Review Status

Submitted

Under Review

Approved

Last updated: January 18, 2026 • View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Related Questions

What intravenous (IV) fluids should be initiated for potassium supplementation in a dialysis patient with hypokalemia?

Can a patient with persistent hyperkalemia be kept for observation until the next dialysis session?

What is the appropriate management for a patient with End-Stage Renal Disease (ESRD) and hyperkalemia, who has a Do Not Resuscitate (DNR) order?

What is not an indication for dialysis among hyperkalemia, metabolic acidosis, and impaired renal function (Creatinine (CR) greater than 3 or Blood Urea Nitrogen (BUN) greater than 100)?

What is the appropriate action for an alert female patient with a history of severe Multiple Sclerosis (MS) and recently diagnosed End-Stage Renal Disease (ESRD), who has a Do Not Resuscitate (DNR) order and presents with hyperkalemia?

What is the best management approach for a hypertensive adult patient with uncontrolled blood pressure of 160/90 mmHg while taking Telmisartan (Telmisartan) 40 mg once daily?

What are the half-lives, degrees of blood pressure improvement, and compelling indications for Angiotensin Receptor Blockers (ARBs), including Losartan, Candesartan, Valsartan, Irbesartan, Olmesartan, Telmisartan, Eprosartan, and Azilsartan, in patients with hypertension, heart failure, and diabetic nephropathy?

What is the recommended treatment for a patient with pus in semen analysis, potentially indicating a bacterial infection, and possibly with a history of sexually transmitted infections (STIs)?

How often should we check Basic Metabolic Panel (BMP) after starting Lasix (furosemide) in a patient with Chronic Kidney Disease (CKD)?

Can valsartan (angiotensin II receptor antagonist) cause itchiness in patients, particularly those with a history of cardiovascular disease or skin conditions?

What is the approach to abdominal examination in a patient with chronic liver disease (CLD), portal hypertension, and ascites?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.